期刊
SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO
卷 142, 期 11-12, 页码 756-763出版社
SRPSKO LEKARSKO DRUSTVO
DOI: 10.2298/SARH1412756I
关键词
renin-angiotensin system; angiotensin II; bradykinin; ACE inhibitors; angiotensin receptor blockers; aliskiren
Research on the renin-angiotensin system (RAS) has contributed significantly to advances in understanding cardiovascular and renal homeostasis and to the treatment of cardiovascular diseases. This review offers a brief history of the RAS with an overview of its major components and their functions, as well as blockers of the RAS, their clinical usage and current research that targets various components of the RAS. Because angiotensin-converting enzyme (ACE) metabolizes two biologically active peptides, one in the kallikrein-kinin system (KKS) and one in the RAS, it is the essential connection between the two systems. ACE releases very powerful hypertensive agent, angiotensin II and also inactivates strong hypotensive peptide, bradykinin. Inhibition of ACE thus has a dual effect, resulting in decreased angiotensin II and increased bradykinin. We described the KKS as well.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据